Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Mar 3;9:429–437. doi: 10.2147/OPTH.S78817

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 Yoshikawa and Takahashi. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License

The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Photograph and spectral domain optical coherence tomography (SD-OCT) findings for case 2.

Notes: (A) Thirty-one months after the first visit. A fundus photograph shows yellow–white lesions of approximately five disk diameters in size. There is no SD-OCT findings in the first visit of case 2. (B) Forty-three months after the first visit. SD-OCT shows subfoveal choroidal neovascularization with retinal edema and subretinal fluid. White arrow denotes longitudinal scans of the SD-OCT. (C) Forty-seven months after the first visit. Intravitreal injections of bevacizumab decreased the choroidal neovascularization and subretinal fluid. (D) Ninety-nine months after the first visit. Fundus photograph and SD-OCT show retinal pigment epithelium atrophy.